Filter Resources

All Resource Types
Posters Sabrina Müller Posters Sabrina Müller

The new discount on combination drug therapies in Germany: First numbers and assessment from a payor perspective

The “GKV Financial Stabilization Act” (GKV-FinStG), introduced in November 2022, brought several changes to the German pricing system for drugs, including a novel discount on pre-selected combination therapies. From October 2023 onwards, German statutory health insurance funds (SHIs) are entitled to a discount of 20 percent of the manufacturers’ prices on outpatient drugs that are prescribed in combination with another drug (for new drugs regulated by AMNOG) as designated by the “Gemeinsamer Bundesausschuss” (G-BA; §35a (3) sentence 4 SGB V). The German government expected medium-term savings of approximately €185 million per year.

Read More
Checklist Amanda Brefo Checklist Amanda Brefo

ITC Feasibility Reporting Checklist

This checklist is designed to support high-quality, regulation-aligned ITC submissions for EU Joint Clinical Assessment.
It helps teams identify and address key reporting requirements early reducing the risk of delays or rejected assessments.

Read More
Whitepaper Sabrina Müller Whitepaper Sabrina Müller

The European Health Technology Assessment for emerging medicinal products

The European Health Technology Assessment (EU-HTA) aims to harmonise HTA across Europe, enhancing efficiency and reducing duplication of work for national authorities. This paper explores key components of the EU-HTA framework, challenges, future perspectives, and implications for pharmaceutical companies, primarily concentrating on drug evaluation over medical devices

Read More
Whitepaper Sabrina Müller Whitepaper Sabrina Müller

Strategic Evidence Generation Planning: Objectives, Requirements, and Processes

Scientific evidence needs might differ substantially between the different stakeholders, but they also vary between countries due to different philosophies in the assessment of healthcare interventions. This requires early Global Evidence Generation planning. This paper deals with the process of developing an Evidence Generation Plan (EGP).

Read More